The TNF induced DBC1 and SIRT1 pathway may be an important pharmacological target to improve metabolic disorders, such as type 2 diabetes, fatty liver disease, and diseases with known associations between inflammation and metabolism. This evidence concerns the gene SIRT1 and type 2 diabetes mellitus.